Phase I/II trial of nab-Paclitaxel, Carboplatin, plus Bevacizumab chemotherapy for patients with advanced Non-Squamous Non-Small Cell Lung Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 03 Mar 2014
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 03 Mar 2014 New trial record